Vivian has launched a new prescription-based treatment in Malta aimed at supporting individuals living with obesity, one of the country’s most urgent health challenges. This new treatment marks a significant step in broadening the range of tools available to healthcare professionals and patients seeking a medically supervised, personalised approach to weight management.

With obesity affecting over 34% of adults in Malta, the new therapy offers an evidence-based solution for those who have struggled to achieve sustainable weight loss through diet and exercise alone by reducing hunger and help managing cravings.

Cravings and hunger are two different challenges. Cravings are wanting specific food regardless of whether you are hungry. Hunger is your body telling you it needs food and any food will satisfy that need. It is thought that the two areas of the brain controlling hunger and cravings may be working against you if you are trying to lose weight.

“We are not positioning this as a quick fix. It is a medically approved option for people who need additional support, especially those for whom emotional eating or ‘food noise’ plays a major role in their weight challenges,” explains Steven Ellul, Vivian’s Head of Sales and Business Development.

“This treatment addresses an often-overlooked aspect of obesity: our psychological relationship with food. Obesity is not just a matter of calories in versus calories out. For many people, it’s tied to deep-rooted emotional triggers that make weight loss extremely difficult.”